Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 25, 2025
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
GlobeNewswire
·
April 25, 2025
– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …
Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
GlobeNewswire
·
April 25, 2025
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed …
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
GlobeNewswire
·
April 25, 2025
Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136 as a monotherapy and in …
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
GlobeNewswire
·
April 25, 2025
Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage …
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
GlobeNewswire
·
April 25, 2025
Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF mutation classes Aurora A kinase …
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
GlobeNewswire
·
April 25, 2025
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced today the presentation of a poster featuring new findings …
Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit
GlobeNewswire
·
April 25, 2025
Hong Kong, April 25, 2025 (GLOBE NEWSWIRE) -- On April 22, 2025, the "Towards the Light: Co-creating a New Global Journey in the AI Field — 2025 AI Intelligent Development Summit" grandly opened at the Hop Hing Hotel in Hong Kong, China. This forum focused …
American Rebel CEO Andy Ross Harnesses Media Appearance on NBC-TV West Palm Beach Affiliate to Amplify Growth Strategy, Propel Brand Expansion and Launch American Rebel Light Beer in Florida
GlobeNewswire
·
April 25, 2025
From Song to Strategy: American Rebel's CEO Andy Ross Shares the Brand's Journey with Sunshine Spotlight Host Fiona Daghir Detailing the Journey of America’s Patriotic Brand to Becoming the Next Great American Success Story. West Palm Beach, FL, April 25, …
Ov Finance Upgrades Blockchain Infrastructure to Deliver Faster, Safer Digital Asset Trading
GlobeNewswire
·
April 25, 2025
Atlanta, GA, April 25, 2025 (GLOBE NEWSWIRE) -- Ov Finance, a financial technology and cryptocurrency company, has announced a major upgrade to its blockchain infrastructure aimed at boosting platform performance, enhancing security, and enabling seamless …
Chameleon Finance Launches Green Finance Initiative to Advance Sustainable Digital Asset Infrastructure
GlobeNewswire
·
April 25, 2025
SEATTLE, WA, April 25, 2025 (GLOBE NEWSWIRE) -- Chameleon Finance, a global financial technology company, has announced the launch of a green finance initiative focused on embedding environmental sustainability into blockchain-based financial systems. This …
ReversingLabs Delivers Most Comprehensive Support for CycloneDX xBOM
GlobeNewswire
·
April 25, 2025
CAMBRIDGE, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- ReversingLabs (RL), the trusted name in file and software security, today announced the launch of leading support for eXtended Bill of Materials (xBOM) capabilities with Spectra Assure™. Available now, …
Advantage Solutions Announces Date for its First Quarter 2025 Financial Results and Conference Call
GlobeNewswire
·
April 25, 2025
ST. LOUIS, April 25, 2025 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) announced today that it will release financial results for the first quarter at 7 a.m. EDT on May 12, 2025, followed by a conference call at 8:30 a.m. EDT on the same day. …
Greenheart Gold Announces Filing of Annual Financial Statements and Provides a Corporate Update
GlobeNewswire
·
April 25, 2025
LONGUEUIL, Québec, April 25, 2025 (GLOBE NEWSWIRE) -- Greenheart Gold Inc. (TSXV: GHRT; OTCQB: GHRTF) (the “Company” or “Greenheart Gold”) is pleased to announce that it has filed its annual financial statements and management discussion and analysis for …
Ndax Becomes The Official Crypto Trading Platform Partner Of The 2025 Stanley Playoffs
GlobeNewswire
·
April 25, 2025
New York, April 25, 2025 (GLOBE NEWSWIRE) -- Ndax, one of Canada's largest crypto trading platforms, and the National Hockey League (NHL®) today announced a new Canadian partnership, naming Ndax the Official Crypto Trading Platform Partner of the NHL …
Adstra Services Launches New Playbook for Growing a Subscription Business
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Adstra Services, a leader in data and identity infrastructure for marketers, today announced the release of its latest whitepaper, “Mastering the Subscription Model: Acquisition, Retention, and Lifetime Value.” …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
April 25, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 25.4.2025 KLO 17.20 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
April 25, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 25 April 2025 at 17.20 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a …
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
GlobeNewswire
·
April 25, 2025
Recommendation is based on Phase 3 EPIDYS trial data that demonstrated Duvyzat (givinostat) provides statistically and clinically meaningful treatment benefits in individuals with Duchenne muscular dystrophy (DMD) If approved by the European Commission, …